Cathie Wood Biond Vax Pharmaceuticals Ltd. Transaction History

Ark Investment Management LLC

  • $10.5 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$2.6 - $3.91 $25,422 - $38,231
-9,778 Closed
0 $0
Q1 2021

May 13, 2021
SELL
$3.1 - $5.95 $98,542 - $189,138
-31,788 Reduced 76.48%
9,778 $37,000
Q4 2020

Feb 12, 2021
BUY
$2.5 - $40.97 $54,275 - $889,458
21,710 Added 109.34%
41,566 $117,000
Q3 2020

Oct 30, 2020
BUY
$23.7 - $51.1 $470,587 - $1.01 Million
19,856 New
19,856 $776,000

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email